23. ja 30. detsembril oleme avatud kell 10.00-18.00. 24.-27. ja 31. detsembril ning 1. jaanuaril puhkame, kauplus on suletud

Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease: Non-Pharmacological Therapies for Alzheimer's Disease 1st ed. 2019 [Kõva köide]

  • Formaat: Hardback, 293 pages, kõrgus x laius: 235x155 mm, kaal: 752 g, 35 Illustrations, color; 10 Illustrations, black and white; XI, 293 p. 45 illus., 35 illus. in color., 1 Hardback
  • Ilmumisaeg: 24-Oct-2019
  • Kirjastus: Springer Verlag, Singapore
  • ISBN-10: 9811396353
  • ISBN-13: 9789811396359
Teised raamatud teemal:
  • Kõva köide
  • Hind: 140,50 EUR*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 165,29 EUR
  • Säästad 15%
  • Lisa soovinimekirja
  • Raamatut on võimalik tellida. Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat.
  • Lisa ostukorvi
  • Kogus:
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Formaat: Hardback, 293 pages, kõrgus x laius: 235x155 mm, kaal: 752 g, 35 Illustrations, color; 10 Illustrations, black and white; XI, 293 p. 45 illus., 35 illus. in color., 1 Hardback
  • Ilmumisaeg: 24-Oct-2019
  • Kirjastus: Springer Verlag, Singapore
  • ISBN-10: 9811396353
  • ISBN-13: 9789811396359
Teised raamatud teemal:

This book discusses the latest research into the highly prevalent neurodevelopmental disease most commonly associated with aging: Alzheimer’s disease (AD). Even after years of research, Alzheimer’s disease is still far from being cured. It presents a range of common symptoms in the form of behavioral and cognitive impairments. This book describes the symptoms and the biology behind them. 

The contents covers latest findings on the genetics involved and various factors and pathways influencing disease development. It also covers various non-pharmacological therapies like immunotherapy, use of natural products, and employing nanotechnology in both the detection and treatment of AD. This book also highlights the role of diet and nutrition in healthy aging. Given its scope, it offers a valuable asset for researchers and clinicians alike. 

Chapter
1. Cognitive Impairment and Rehabilitation in Alzheimer's Disease.
Chapter
2. Alzheimer's - a progressive brain disease: causes, symptoms and prevention.
Chapter
3. Diet and nutrition in Alzheimer's disease and healthy aging.
Chapter
4. Carbon nanostructures based materials: A novel tools for detection of Alzheimer's disease.
Chapter
5. Oxidative Stress in Alzheimer's Disease: Molecular Hallmarks of Alzheimer's Dementia.-
Chapter
6. Strengthen Alzheimer's Awareness through Biomusic.
Chapter
7. Diagnosis of Alzheimer's Disease Using Brain Imaging: State-of-the-art.-
Chapter
8. A Review of the Relationship Between Gut Microbiota and Memory.-
Chapter
9. Stem cell therapy: A great leap forward in Alzheimer's treatment.-
Chapter
10. Diet and Nutrition in Alzheimer's disease & Healthy Aging.-
Chapter
11. Genetics, Neuronal Pathways, and Electrophysiology of Alzheimer's disease.
Chapter
12. Biotechnology and Bioinformatics Applications in Alzheimer's disease.
Chapter
13. Neurobiological Mechanisms Involved in the Pathogenesis Of Alzheimer's Disease.
Chapter
14. Immunotherapy in Alzheimer's disease.
Dr Ghulam Md Ashraf, currently working as an Associate Professor at King Fahd Medical Research Centre, King Abdulaziz University, Saudi Arabia, completed his PhD in Biochemistry at Aligarh Muslim University, Uttar Pradesh, India. His main research interests are in Proteomics and Neurology. He is also a Research Consultant/Supervisor at Glocal University, India, and an Honorary Faculty Member at the Novel Global Community Educational Foundation (NGCEF), Australia. He has acted as a Principal Investigator or Co-Investigator in various research projects funded by reputed funding agencies, e.g. the Deanship of Scientific Research (DSR), King Abdulaziz University, Saudi Arabia and Strategic Technologies Research Program, King Abdulaziz City for Science and Technology (KACST), Saudi Arabia. He is a Member of the Editorial Board of various journals, e.g. Scientific Reports (Nature Publishing Group), Journal of Proteomics (Elsevier), Frontiers in Aging Neuroscience, etc. He is also affiliated with the Protein Society, USA, the Science Advisory Board, and Saudi Society for Genomics and Molecular Oncology, Saudi Arabia. He has published 178 articles in various national and international journals. Dr. Athanasios Alexiou is a Mathematician with a Ph.D. in Bioinformatics Algorithms and Mathematical Modeling in Biology and a two-year Postdoctoral Research Fellowship in Neuroinformatics Applications. He currently serves as an Honorary Vice President and Faculty Member at the Novel Global Community Education Foundation (NGCEF), Australia and as Head of the Scientific Advisory Board of the AFNP Med Company in Austria. His main research field is Biomedical Informatics, with a special interest in Medical Decision Support Systems, Algorithms in Neuroinformatics and Computational Biomedicine, Neurodegenerative Diseases and Biomarker Modeling. He is an Associate Editor of the journals Genetics, Pharmacology and Sociology, a Guest Associate Editor of the Frontiers Neuroscience Journal for the Research Topic 'The Alzheimer's Disease Challenge', and the author/co-author of several peer-reviewed scientific papers in various journals and books.

Tellige see raamat tutvumiseks meie kauplusesse!Raekoja plats 11, 51004 Tartu

Juhul, kui soovite raamatuga enne ostu tutvuda, siis palun sisestaga allpool oma nimi ning e-mail.
Võimaluse korral tellime raamatu poodi ning teavitame ka teid, kui raamat on müügile jõudnud.

* - väljad on kohustuslikud